- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00447655
Improving Outcomes Following Limb Loss: PALS Plus (PALS-PLUS)
12. december 2017 opdateret af: Johns Hopkins University
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
Study Design and Participants: The prospective clinical trial will use a two group, lagged-control design to evaluate the intervention at five health care facilities.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
Improvements in primary and secondary outcomes will result through the impact on self efficacy, patient activation, catastrophizing and social support.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
400
Fase
- Fase 2
- Fase 1
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21239
- Good Samaritan Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 85 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Adults (aged 18-85 years) of both sexes and all races admitted to one of the seven participating acute care hospitals or rehabilitation facilities for an amputation procedure and/or treatment immediately following an amputation procedure, including traumatic amputations as well as amputations due to complications for diabetes mellitus, peripheral vascular disease, and malignancy.
- Women and minority patients will be represented in the trial according to the gender and race/ethnic prevalence of patients receiving treatment at the designated hospital and rehabilitation centers.
Exclusion Criteria:
Criteria for exclusion from the study will include:
- Age less than 18 or over 85 years; and
- Inability to communicate in written or spoken English.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
|---|
|
Primary outcome measures are: pain, depressed mood, and positive mood.
|
Sekundære resultatmål
Resultatmål |
|---|
|
Secondary outcome measures are: function, participation and bothersomeness of limitations
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Stephen T Wegener, PHD, Johns Hopkins University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. marts 2007
Primær færdiggørelse (Faktiske)
1. august 2009
Studieafslutning (Faktiske)
1. august 2009
Datoer for studieregistrering
Først indsendt
14. marts 2007
Først indsendt, der opfyldte QC-kriterier
14. marts 2007
Først opslået (Skøn)
15. marts 2007
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. december 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
12. december 2017
Sidst verificeret
1. december 2017
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- CDC R01DD000153
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .